(The Epoch Times)—The U.S. Supreme Court on Dec. 18 agreed to hear TikTok’s case challenging a law requiring its China-based parent company to divest of the app by Jan. 19, 2025.
The court will hear oral arguments on Jan. 10, 2025.
TikTok had challenged the divestment law as unconstitutional under the First Amendment, and a three-judge panel in federal court had upheld the law earlier this month.
TikTok then appealed to the high court asking for a pause of the Jan. 19 deadline and asking it to treat its petition as one for review.
The Supreme Court wrote on Dec. 18 that it will hear arguments in the case before deciding whether to pause the deadline.
When President Joe Biden signed the Protecting Americans from Foreign Adversary Controlled Applications Act (PAFACA) into law, it started a 270-day countdown for ByteDance to divest of TikTok or else stop operating the app in the United States. The law targets apps owned or controlled by foreign adversaries, in this case, the Chinese communist regime.
The law also allows the president to issue a one-time extension of a maximum of 90 days.
President-elect Donald Trump has suggested he can facilitate a sale of TikTok, which would prevent what TikTok calls a “ban.” TikTok is arguing the deadline should be paused so the new administration can make the call.
The Justice Department argued the law did not violate the First Amendment because it targeted ownership by a foreign adversary for national security reasons, and that it did not target content.
The Supreme Court directed parties to argue on “whether the Protecting Americans from Foreign Adversary Controlled Applications Act, as applied to petitioners, violates the First Amendment.”
The parties have a Dec. 27 deadline to file opening briefs, and a Jan. 3, 2025, deadline for reply briefs. Amicus briefs have a Dec. 27 deadline. Oral arguments will last two hours.
This is developing and will be updated.
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.